Home / Intelligence / White Papers / Reimagining Work Models in the Life Sciences: Implications for the Future of Work
The Changing Work Model for Life Sciences.
When considering a work environment that will be sustainable in this new working world, life sciences companies have been examining policies and addressing how and where employees should work though lack objective sources of data to make informed decisions. The life sciences industry as a whole lacks work-model data. Like many organizations globally, certain work-model assumptions need to be validated or debunked. For example,
- Employees should be at company headquarters if or when key stakeholders are.
- Supervisors should be at company headquarters if or when their direct reports are.
- People receive more effective and frequent development from supervisors when both are at company headquarters.
A significant challenge for organizations is loss of talent acquired during the COVID-19 pandemic and acquisition of new talent post-COVID, further constrained by relocation requirements to company headquarters (HQ) that are in geographic locations with negative cumulative net flows of populations (such as San Francisco and New York City). Commercial Operations executives from mid-large size life science companies listed complexity of hybrid work teams and career development as their most pressing challenges. Specifically, the main barrier to developing their most critical commercial capabilities was talent. Half had already increased salary levels and elevated role levels and titles to fill Commercial Operations vacancies.
To ensure that future policies about where and how employees in the life sciences will work are based on sound, objective sources of data, TGaS Advisors, a division of Trinity Life Sciences, led an in-depth study for a pharmaceutical company that selected a functional department within Commercial Operations to participate in a research pilot to evaluate both Achievement of Intended Outcomes of work and impact on personal factors.
Complete the form below to access the full white paper
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.
Related Intelligence
Briefs
2025 Annual State of Learning & Development in Life Sciences
Through the 2020s, life sciences leaders have dealt with one challenge after another. The shock of the COVID-19 pandemic. Sticky inflation. Return-to-office mandates. The intense pressure to perform in the face of disruptive challenges has proven constant. For commercial learning and development, also known as commercial L&D, this has presented new roadblocks and innovations alike, […]
Read More
Briefs
Leading the Evolution: Navigating AI and Pharma Market Trends
How are Commercial, Medical and Market Access organizations evolving to develop capabilities and accelerate innovation in 2025 and beyond? Executive leaders are focused on making informed organizational decisions to propel the evolution of capabilities in this rapidly changing global economy. As you strategize to optimize structure, talent and capabilities to excel in the future, this Advisory Brief brings you critical insights gleaned from the recent TGaS Advisors’ 2025 Spring Summit.
Read More
Blog
Is Medical Omnichannel Poised for Growth?
79% of respondents are predicting an increase in spend in Omnichannel capabilities for Medical Affairs in 2025, according to a recent TGaS survey fielded in September 2024.* This predicted increase for Medical Omnichannel indicates that there is a real need to find ways to inform, educate and engage HCPs beyond the traditional in-person channel. What […]
Read More